The Walker Webcast Dr. Ben Ebert, President and CEO of Dana-Farber Cancer Institute
May 1, 2025
Dr. Ben Ebert, President and CEO of Dana-Farber Cancer Institute and a leading cancer researcher, shares insights on the future of oncology. He discusses the importance of collaboration in Boston's cancer research ecosystem and how institutions work together to foster innovation. Ebert also delves into groundbreaking technologies, like blood biopsies and AI, set to transform cancer detection and treatment. His hope for the next five years focuses on advancements in understanding blood cancers and the role of community support in driving research funding.
AI Snips
Chapters
Transcript
Episode notes
Collaboration Trumps Competition
- Cancer research institutions collaborate extensively rather than competing aggressively.
- Joint projects and shared data accelerate discoveries beyond what isolated efforts could achieve.
Attracting Top Talent
- The intellectual and collaborative environment is key to attracting top cancer researchers.
- Dana-Farber’s combined clinical and research culture motivates people beyond compensation alone.
Entrepreneurial Cancer Research
- Cancer research is entrepreneurial with scientists pursuing novel underserved areas or targets.
- Dana-Farber invests extra effort in rare cancers that others neglect, like pediatric cancers.